NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000044475

Registered date:20/06/2021

An Observational Study of Japanese Participants With X-linked Retinitis Pigmentosa

Basic Information

Recruitment status Complete: follow-up continuing
Health condition(s) or Problem(s) studiedX-Linked Retinitis Pigmentosa
Date of first enrollment2021/07/30
Target sample size15
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeVisual Function Up to Day 30 Visual function will be assessed using visual acuity. Retinal Structure Up to Day 30 Retinal structure will be assessed using spectral domain optical coherence tomography (SDOCT). Retinal Function Up to Day 30 Retinal function will be assessed using static visual field testing.
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum5years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria- Are unable or unwilling to undertake consent or clinical testing - Participated in another research study and had intraocular surgery within 3 months of screening - Significant ophthalmologic diseases

Related Information

Contact

public contact
Name Personnel Medical Information Center
Address 3-5-2 Nishikanda, Chiyoda-ku, Tokyo, Japan Japan 101-0065
Telephone 0120-183-275
E-mail DL-JANJP-JCO_TL_TSG_EMP@its.jnj.com
Affiliation Janssen Pharmaceutical K.K. Medical Information Center
scientific contact
Name Hirotaka Numaguchi
Address 3-5-2 Nishikanda, Chiyoda-ku, Tokyo, Japan Japan
Telephone 0120-183-275
E-mail DL-JANJP-JCO_TL_TSG_EMP@its.jnj.com
Affiliation Janssen Pharmaceutical K.K. R&D Div. Clinical Science Div. Clinical Development Dept. Medical Group